Sign in

CIK 0000014272 · Large accelerated filer

BRISTOL MYERS SQUIBB CO

Sign in to watch
Ticker
BMY
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
220790350
Phone
6092524621
Business address
ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NJ, 08543

Securities

  • BMY Bristol-Myers Squibb Company Common Stock NYSE
  • CELG-RI Rights NYSE
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$677,826
in 3 filings

Net −$677,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Massacesi Cristian −$403K EVP,Chief Med Offr,Head of Dev sold 25% of stake
  2. Haller Julia A −$241K Director sold 11% of stake
  3. Holzer Phil M −$34K SVP and Controller sold 3% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-09-30 YALE PHYLLIS R Director Grant or award · Deferred Share Units +581.5 $58.04 $34K 21,463.09
2023-09-30 Storch Gerald L Director Grant or award · Deferred Share Units +624.57 $58.04 $36K 80,538.07
2023-09-30 Samuels Theodore R. II Director Grant or award · Deferred Share Units +839.94 $58.04 $49K 40,700.6
2023-09-30 Rice Derica W Director Grant or award · Deferred Share Units +624.57 $58.04 $36K 17,499.99
2023-09-30 Haller Julia A Director Grant or award · Deferred Share Units +624.57 $58.04 $36K 21,797.26
2023-09-30 Bhatt Deepak Director Grant or award · Deferred Share Units +145.37 $58.04 $8K 5,283.2
2023-09-30 Arduini Peter J Director Grant or award · Deferred Share Units +581.5 $58.04 $34K 45,997.95
2023-08-24 Powell Ann EVP, Chief Human Resources Sale −17,986 $61.25 $1.1M 27,868.09
2023-08-03 Plenge Robert M EVP, Chief Research Officer Sale −732 $61.14 $45K 6,584
2023-07-01 Weese Michelle EVP, Corporate Affairs Option exercise +1,885 4,135
2023-07-01 Weese Michelle EVP, Corporate Affairs Shares withheld for taxes −682 $63.95 $44K 3,453
2023-07-01 Weese Michelle EVP, Corporate Affairs Option exercise · Restricted Stock Units −1,885 3,770
2023-07-01 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Option exercise +9,357 52,032
2023-07-01 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Shares withheld for taxes −4,787 $63.95 $306K 47,245
2023-07-01 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Option exercise · Restricted Stock Units −9,357 0
2023-06-30 YALE PHYLLIS R Director Grant or award · Deferred Share Units +527.76 $63.95 $34K 20,689.93
2023-06-30 Storch Gerald L Director Grant or award · Deferred Share Units +566.85 $63.95 $36K 79,179.99
2023-06-30 Samuels Theodore R. II Director Grant or award · Deferred Share Units +762.31 $63.95 $49K 39,494.79
2023-06-30 Rice Derica W Director Grant or award · Deferred Share Units +566.85 $63.95 $36K 16,720.53
2023-06-30 Haller Julia A Director Grant or award · Deferred Share Units +553.94 $63.95 $35K 20,978.36

Page 41 of 56 · 1,112 trades